An approach of total endoscopic atrial myxoma resection without robotic assistance

一种无需机器人辅助的全内镜下心房黏液瘤切除术方法

阅读:2

Abstract

BACKGROUND: Conventional surgery presents significant challenges for elderly patients with atrial myxoma and ascending aorta calcification. This study aims to evaluate the feasibility and safety of total thoracoscopic resection of atrial myxoma. METHODS: A total of 83 patients who underwent totally thoracoscopic resection of atrial myxoma between January 2013 and April 2024 were retrospectively analyzed. Three 1.0-2.0-cm thoracic incisions were made in the right chest, and all procedures were conducted under totally thoracoscopy. Right atrial myxomas were resected via a right atrium approach, while left atrial myxomas were removed through an interatrial groove approach. For the 46 patients with ascending aortic plaque or calcification, the operations were performed on the beating heart without aortic cross-clamping. RESULTS: The totally thoracoscopic resection of atrial myxoma was successfully performed in all patients without in-hospital mortality or a switch to the sternotomy approach. The duration of operation, CPB time, and aortic cross-clamp time in the beating-heart group were shorter than in the arrested-heart group. There were no statistically significant differences between the groups in mechanical ventilation time, duration of ICU, postoperative hospital stay, and postoperative 24-h drainage volume. The rate of tracheal extraction in the operating room was higher in the beating-heart group than that in the arrested-heart group. None of the patients required a blood transfusion or experienced serious complications. CONCLUSION: Total thoracoscopic resection is a feasible and safe method for addressing atrial myxomas, particularly in elderly patients with ascending aortic calcification and persistent cardiac failure.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。